Wandercraft unveils Atalante X: A new generation of the self-balancing exoskeleton

A new step towards mobility for all! 

Paris, April 22, 2022, Wandercraft, a leading healthtech company in dynamic robotics and exoskeleton technology, today unveils Atalante X: an autonomous exo that accompanies the patient at all stages of rehabilitation, with a physiologic walking pattern. Pioneer of dynamic walking robotics, Atalante X is hands-free, without crutches, easy to use and intuitive. It adapts progressively to the needs of patients, from their very first steps to the most playful sessions.  

Atalante X is a paradigm changing exoskeleton for gait rehabilitation. Even more disruptive than its predecessor, it features a new mechanical design for the feet coupled with state-of-the-art dynamic walking algorithms. It provides a physiologic and stable walk pattern, reducing the effort of patients as well as their therapist. Thus, Atalante X opens the path to sessions in an upright position with a minimum of effort while ensuring the safety of the patient. Particularly adapted to people with neurological deficiencies such as hemiparesis, paraparesis or paraplegia, it gives a realistic and optimized walk for better care and rehabilitation.  

Several innovations signed Wandercraft  

  • Self-stabilization for hands-free walk. With the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments. It is designed to help carry out lower limb, trunk and upper limbs reinforcement exercises in a safe upright position. 
  • Dynamic verticalization for early care. EarlyGait promotes early management of patients with severe gait disorders and supports them in their first steps with a self-stabilizing and customizable gait pattern. By starting with a small step gait, patients feel confident in the first few uses of Atalante X and can progress to a more natural gait pattern. 
  • An active gait to increase intensity. EarlyGait promotes early treatment in patients with severe gait disorders and helps them in their first steps thanks to its self-stabilizing and customizable gait pattern. By starting with a small step gait, patients feel confident from the start and can make bigger progress towards a more natural gait pattern. 
  • A multidirectional locomotion for task orientation. Atalante X automatically generates optimized and realistic walking kinematics adapted to the body type and abilities of each patient. Atalante X offers multi-directional gait, opening new possibilities to move in space and carry out diverse and fun treatment sess 
  • WanderTouch patient tracking and reporting. WanderTouch offers an intuitive interface for easy setup and monitoring throughout the patient's rehabilitation journey. 

According to Dr. Rebecca SAUVAGNAC, physiatrist and clinical director at Wandercraft, “ Gait training exoskeletons, such as Atalante X, are innovative tools in the management of people with walking impairment. They maximize rehabilitation training; in the hope of improving recovery after a neurological lesion; and in preventing the appearance of complications secondary to prolonged immobilization. Clinical studies comparing Atalante to conventional rehabilitation are undergoing to prove the potential clinical benefits.  In the long term and taking into consideration the current progress in terms of the management of Neurological lesion, particularly with the appearance of new treatments that give hope of repairing or supplementing the nervous system, exoskeletons have their place in maintaining the body in a state of general good health for people in wheelchairs”. » 

About WANDERCRAFT

Wandercraft was founded in 2012. A group of engineers refused to accept the status quo of wheelchair use, believing they could create a better solution for mobility and autonomy. Wandercraft builds autonomous walking exoskeletons. Its first version, Atalante, was commercialized in 2019 and is used by rehabilitation and neurological hospitals in Europe and North America. Atalante provides innovative care for many patients based on realistic, hands-free, crutch-free locomotion.   

CONTACT

Licence K

Jean-François Kitten – CEO
11, rue Tronchet – 75008 Paris – France
meet@licencek.com
+33 (0)1 45 03 21 77

Rejoignez-nous :